Global Capital Confidence Barometer – Does Seizing Competitive Advantage Mean Deals Take Center Stage?

Figure 1 What is your perspective on the state of the economy today at the global level?

by Ernst & Young
Deals take center stage as companies reinvent their corporate strategy in response to a permanently reshaped landscape. Everything is changing for executives — except the expectations of their investors and stakeholders around higher growth and returns. Profitable growth is a mainstay demand of business. The list of what is changing includes unprecedented technological advances, the blurring of sector lines, uneven geographic growth, workforce dynamics and more geopolitical uncertainty. […] Read more

Asia-Pacific Health Industries 2016: Keeping You Up-To-Date With The Latest Developments

Asia-Pacific Health Industries Newsletter 2016: Keeping You Up-To-Date With The Latest Developments

by PricewaterhouseCoopers
In recent years there has been a shift in the nature of healthcare, i.e., from reactive to preventative. An integral component of this shift has been the emergence of personalised medicine. Personalised medicine is a model that segments patients by risk of developing a specific disease, based on their genetic profile. This includes, molecular diagnosis and use of biomarkers to segment populations. […] Read more

Deal Capsule: Transactions In Chemicals & Pharmaceuticals July 2016

Table 1-2 Pharmaceuticals July 2016

by KPMG
The number of completed deals remained high in both sectors in HY1 2016. While total deal value for pharmaceuticals decreased, chemicals witnessed a 40% increase in HY1 2016 versus HY1 2015. Pharmaceutical M&A was impacted by stock market volatility, while new US regulatory rules struck down the $160 billion Pfizer-Allergan merger. Oncology and dermatology were key areas of interest for big pharma, who were especially keen on acquiring biotech assets. […] Read more

Plotting A New Course: The Impact Of Brexit On M&A Activity

Figure 1 UK M&A volumes and values (H1 2005 - H1 2016)

by Deloitte
In the aftermath of the EU referendum vote, the reaction from currency and stock markets has been swift. It is clear that Brexit has shaken investor confidence. However, M&A markets are typically driven by longer term decision making processes. Brexit has created uncertainties and some M&A plans are being put on hold. But we think the post-Brexit tumult creates opportunities as well. In the coming months we expect there will be both threats to M&A dealmakers and unique opportunities for them. […] Read more

‘Western’ Professional Ethics Challenged By Foreign Acquisitions: German Managers’ Patterns Of Interpretation Surrounding Chinese And Indian Investors

Figure 1 Predominant descriptions-interpretations of foreign investors

by Elsevier Ltd.
In times of globalisation managers are often involved in crossborder acquisitions. This contribution analyses how German managers interpret their new business partners after acquisition of their companies by foreign investors from China and India. At first glance, managers appear to extend a cosmopolitan welcome to the new owners. […] Read more

2016 Asian Trailblazers Study: Masters Of Multitasking And Transformation

Figure 1. Asian Trailblazers are fine-tuning their strategy along several areas

by Willis Towers Watson
In 2012, an event occurred that went largely unnoticed. For the first time, the percentage of Asia Pacific-headquartered companies in the Fortune Global 500 outnumbered those headquartered in Europe and North America. That year, 36% of companies in the Fortune Global 500 were headquartered in Asia Pacific. Of these 181 organisations, 69 were headquartered in Mainland China and 68 in Japan. […] Read more

Global Capital Confidence Barometer – Buying And Bonding: Alliances Join M&A As Engines Of Growth

Figure 1 Key MA findings

by Ernst & Young
Our latest Global Capital Confidence Barometer continues to find a strong acquisition appetite together with a growing inclination to forge new alliances. Prolonged economic challenges are driving investment decisions, leading companies to ally and cooperate to generate growth as well as compete and acquire to gain market share. […] Read more

Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

by KPMG
While the number of completed pharma deals were slightly higher in Q1 2016 versus Q1 2015, deal value was far lower in the absence of any >$10 billion completions. Only one deal exceeded $5 billion in Q1 2016 (versus 8 in Q1 2015). Specialization continues to be a driving force in Q1 2016, especially in sectors such as OTC, rare diseases and oncology. Declines in transaction values were also witnessed in chemicals. Downstream specialty chemicals was the leading focus area, notably in applications, resins and agrochemicals. […] Read more

Taxation Of Cross-Border Mergers And Acquisitions: China 2016

Taxation Of Cross-Border Mergers And Acquisitions: China 2016

by KPMG
Since the 2014 edition of this publication, the People’s Republic of China’s (PRC) tax provisions relevant to mergers and acquisitions (M&A) have changed significantly. China is at the forefront of implementing the Organisation for Economic Co-operation and Development (OECD) Base Erosion and Profit Shifting (BEPS) program and issued the Chinese language versions of the BEPS deliverables. […] Read more

Are you sure you
want to log out?

Request a Brochure

Request a Brochure

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!

Book a Demo

Book a Demo

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!